Please login to the form below

Digital applications are transforming the market access landscape

Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.

Over the last few years we have seen how digital technology has been harnessed to improve health outcomes. With the rapidly evolving market access landscape, we are now on the cusp of a huge acceleration in the use of digital applications to explore value, gain strategic advantage and provide innovative market access solutions.

To date, use of digital technology has been conservative, focused on customer-facing applications for market access; however, it has the potential to inform strategy and become an essential enabler in realising the commercial vision for pharmaceutical and biotechnology companies. Organisations can leverage this technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.

New cloud technology provides an improved framework for real-time decision-making in market access. The inbuilt case logic is able to identify risks and maximise opportunities at all levels, from assets in preclinical development through to country HTA submissions. This facilitates increased collaboration by linking global thinking with affiliate needs, and encouraging effective multifunctional dialogue for product assessment, evidence generation planning and HTA preparation.

By having rapid aggregation and dissemination of data within a centralised system, this not only enhances efficiency but also allows companies to proactively address their market access needs. They can anticipate payer requirements, prioritise resources, plan evidence generation, get a head start on HTA and reimbursement submissions, and provide a useful institutional memory.

Although the process of change can be the greatest barrier to adoption of technology, this year we have been presented with more opportunities than ever before to develop more consistent and structured business processes with our clients through our digital application methodology, which helps get them ready for market access and allows them to make faster and more informed decisions.

It’s inevitable that digital applications will be used within market access, and we would encourage everyone to evaluate how digital technology can better enable processes and requirements. Only then can you ensure that your company fully unlocks and optimises product value and elevates their market access competitiveness.

Read the case study: www.prmaconsulting.com/casestudy

14th January 2019

Share

Tags

Company Details

PRMA Consulting Ltd

+44 (0)1252 786284

Contact Website

Address:
Linea House
Harvest Crescent
Ancells Business Park
Fleet
GU51 2UZ
United Kingdom

Latest content on this profile

Transforming the market access landscape with digital applications
Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products.Read the article >>  https://www.prmaconsulting.com/digital_applications_whitepaper/index.html?utm_source=PMLiVE&utm_medium=HubArticle&utm_campaign=DigitalTransThis new article helps you to:appreciate why digital applications are transforming the value and access functionsunderstand how new technology is informing direction and becoming an essential enabler in realizing visiongain insight into considerations for re-evaluating your technology and your suppliers.
PRMA Consulting Ltd
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.
PRMA Consulting Ltd
Achieve up to 80% auto-population of your first draft HTA submission

PRMA Consulting Ltd
Video: Drive payer submission readiness for your Phase 2 and 3 products
Transform your market access processes with the PRMA Healthcheck®  late module. The digital application encourages collaboration with integrated decision-making between affiliate and global functions to build an evidence generation plan. Efficiency is increased through the systematic assessment of payer evidence readiness for your product against actual submission template requirements with a visual heatmap. An organizational vision and action plan to anticipate and mitigate value challenges to optimize payer readiness.
PRMA Consulting Ltd
Drive payer submission readiness for your Phase 2 and 3 products
PRMA Healthcheck® late module celebrates over 40 readiness assessments successfully delivered and announces a new version release.
PRMA Consulting Ltd